Roche Venture Fund News Archive

News archive

COUR Pharmaceuticals Secures $105 Million in Series A FinancingRVF participates in Mironid's Funding RoundDiogenX raises EUR27.5M Series A financingGermany-based company acquires lino BiotechEnliven Therapeutics Closes Merger with Imara and Private Placement of USD161 MillionBionano Genomics to Acquire Purigen BiosystemsBonum Therapeutics Announces a $93M Series Financing to Advance a Novel and Validated Class of Conditionally Active TherapiesRoche acquires Good Therapeutics to complement next generation PD1-IL2 therapeuticsJasper Therapeutics Closes Transaction With Amplitude Healthcare Creating a Publicly Traded Biotechnology CompanyRoche Venture Fund invests in the seed financing of Thelium TherapeuticsGlycoEra AG announced today the close of a CHF 45 million ($49 million) Series A financing roundEntrada Therapeutics Announces Closing of Initial Public OfferingJasper Therapeutics Closes Transaction With Amplitude Healthcare Creating a Publicly Traded Biotechnology CompanyTango Therapeutics, Inc.closes merger with BCTG Acquisition CorpTempest Closes Merger with Millendo and Completes PIPE Financing23andMe Successfully Closes its Business Combination with VG Acquisition Corp.Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSsSoteria Biotherapeutics launches with USD42 Million Series A Financing led by Roche Venture Fund and 5AM VenturesJasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell TransplantationEloxx Pharmaceuticals Acquires Zikani TherapeuticsMerck Completes Acquisition of Pandion TherapeuticsTempest and Millendo Announce Proposed Merger AgreementEnthera Pharmaceuticals extends Series A financing, raising a total of €35 millionEnliven Therapeutics Launches With Vision Of Advancing Medicine And Restoring LivesAligos Therapeutics announces Pricing of Initial Public OfferingC4 Therapeutics announces Pricing of an Upsized Initial Public OfferingPalladio Biosciences completes USD20 Million Series B FinancingBCTG Acquisition Corp. Announces Pricing of Upsized $145 Million Initial Public OfferingVaxcyte Announces Pricing of Upsized Initial Public OfferingRoche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic useJasper Therapeutics Announces Expansion of Series A Financing, Bringing Total Corporate Fundraising to More than $50 MillionRoche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophyBlack Diamond Therapeutics Closes $85 Million Series C FinancingPurigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation PlatformNewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare DiseasesAllakos Announces AK002 Met All Prespecified Primary and Secondary Endpoints in Phase 2 Randomized, Double-Blind, Placebo-Controlled Study in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE)Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer DetectionIDEAYA Announces Pricing of Initial Public OfferingArch Oncology Raises $50 Million Series B FinancingPfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet TherapeuticsEntrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics PlatformAllakos announces Pricing of Initial Public OfferingRoche joins Intel & iSeed as investors in Care Innovations to expand its integrated diabetes management solutions with mySugrNMD Pharma raises €38M (~USD 47 Million) SERIES A Financing. Inkef Capital and Roche Venture Fund join investor syndicateIDEAYA Biosciences Raises $94 Million Crossover Series B FinancingPandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs for Autoimmune and Inflammatory DiseasesSyapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in OncologymySugr joins the Roche FamilyAileron Therapeutics Announces Pricing of Initial Public OfferingSenseonics Announces Pricing of $41 Million Underwritten Offering of Common StockVivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseasesCiVi Biopharma Receives Worldwide Exclusive License to Develop a Novel, RNA Targeted Drug Against PCSK-9Tioma Therapeutics Announces $86 Million Series A FinancingViewics Secures $10.5 Million in Capital, Closes Funding to Bring Advanced Analytics to HealthcareOmicia Raises $23 Million in Series B FundingPurigen Biosystems Receives $18.2M in Series A Financing led by 5AM Ventures and Roche Venture FundSecond Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture FundLumos Pharma raises $34 million in Series B financing

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement